Cloning, characterization and expression of the gene that encodes the major neutralization-specific antigen of African horsesickness virus serotype 3 Free

Abstract

The gene encoding the outer capsid protein, VP2, of African horsesickness virus serotype 3 (AHSV-3) has been sequenced in its entirety from cDNA clones of the segment 2 RNA, and compared with the previously published VP2 gene sequence of AHSV-4. AHSV-3 genome segment 2 was shown to be 3221 nucleotides in length, encoding a protein of 1057 amino acids with a 50·5 % identity to the amino acid sequence of AHSV-4 VP2. Two areas of high variability (approximately 35 % identity) were identified. The N-proximal variable region (amino acids 128 to 309) exhibited significant hydro-philicity, suggesting a possible role in the determination of the serotype-specific immune response. VP2 of AHSV-3 has furthermore been expressed in a baculo- virus expression system. The expressed protein was shown to react specifically with an anti-AHSV-3 serum in Western blots. Antibodies raised in rabbits and guinea-pigs against the recombinant VP2 neutralized the virus in a plaque reduction assay, confirming the identity of VP2 as the major neutralization-specific antigen of AHSV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-12-3629
1994-12-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/12/JV0750123629.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-12-3629&mimeType=html&fmt=ahah

References

  1. Bremer C. W. 1976; A gel electrophoretic study of the protein and nucleic acid components of African horsesickness virus. Onderste-poorl Journal of Veterinary Research 43:193–200
    [Google Scholar]
  2. Bremer C. W., Huismans H., Van Dijk A. A. 1990; Characterization and cloning of the African horsesickness virus genome. Journal of General Virology 71:793–799
    [Google Scholar]
  3. Burrage T. G., Trevejo R., Stone-Marschat M., Laegreid W. W. 1993; Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2. Virology 196:799–803
    [Google Scholar]
  4. Cashdollar L. W., Chmelo R., Esparza J., Hudson G. R., Joklik W. K. 1984; Molecular cloning of the complete genome of reovirus serotype 3. Virology 133:191–196
    [Google Scholar]
  5. Fukusho A., Ritter G. D., Roy P. 1987; Variation in the bluetongue virus neutralization protein VP2. Journal of General Virology 68:2967–2973
    [Google Scholar]
  6. Ghiasi H., Fukusho A., Eshita Y., Roy P. 1987; Identification and characterization of conserved and variable regions in the neutralizing VP2 gene of bluetongue virus. Virology 160:100–109
    [Google Scholar]
  7. Grubman M. J., Lewis S. A. 1992; Identification and characterization of the structural and nonstructural proteins of African horsesickness virus and determination of the genome coding assignments. Virology 186:444–451
    [Google Scholar]
  8. Holmes I. H. 1991; Family Reoviridae . In Classification and Nomenclature of Viruses. Archives of Virology, Supplementum 2:188–189
    [Google Scholar]
  9. Howell P. G. 1962; The isolation and identification of further antigenic types of African horsesickness virus. Onderstepoort Journal of Veterinary Research 29:139–149
    [Google Scholar]
  10. Huismans H., Erasmus B. J. 1981; Identification of the serotype- specific and group-specific antigens of bluetongue virus. Onderstepoort Journal of Veterinary Research 48:51–58
    [Google Scholar]
  11. Huismans H., van der Walt N. T., Cloete M., Erasmus B. J. 1987; Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep. Virology 157:172–179
    [Google Scholar]
  12. Inumaru S., Roy P. 1987; Production and characterization of the neutralizing antigen VP2 of bluetongue virus serotype 10 using a baculovirus expression vector. Virology 157:472–479
    [Google Scholar]
  13. Iwata J., Yamagawa M., Roy P. 1992; Evolutionary relationships among the gnat-transmitted orbiviruses that cause African horse sickness, bluetongue, and epizootic hemorrhagic disease as evidenced by their capsid protein sequences. Virology 191:251–261
    [Google Scholar]
  14. Kozak M. 1987; An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Research 15:8125–8148
    [Google Scholar]
  15. Kyte J., Doolittle R. F. 1982; A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology 157:105–120
    [Google Scholar]
  16. Laviada M. D., Arias M., Sánchez-Vizcaíno J. M. 1993; Characterization of African horsesickness virus serotype 4-induced polypeptides in Vero cells and their reactivity in Western immuno-blotting. Journal of General Virology 74:81–87
    [Google Scholar]
  17. Mcintosh B. M. 1958; Immunological types of horsesickness virus and their significance in immunization. Onderstepoort Journal of Veterinary Research 27:465–538
    [Google Scholar]
  18. Mizukoshi N., Sakamoto K., Iwata A., Tsuchiya T., Ueda S., Apiwatnakorn B., Kamada M., Fukusho A. 1993; The complete nucleotide sequence of African horsesickness virus serotype 4 (vaccine strain) segment 4, which encodes the minor core protein VP4. Virus Research 28:299–306
    [Google Scholar]
  19. Nel L. H., Huismans H. 1990; A comparison of different cloned genome segments of epizootic haemorrhagic disease virus as serogroup-specific probes. Archives of Virology 110:103–112
    [Google Scholar]
  20. Paeratakul U., de Stasio P. R., Taylor M. W. 1988; A fast and sensitive method for detecting specific viral RNA in mammalian cells. Journal of Virology 62:1132–1135
    [Google Scholar]
  21. Possee R. D., Howard S. C. 1987; Analysis of the polyhedrin gene promoter of the Autographa californica nuclear polyhedrosis virus. Nucleic Acids Research 15:10233–10248
    [Google Scholar]
  22. Roy P. 1989; Bluetongue virus genetics and genome structure. Virus Research 13:179–206
    [Google Scholar]
  23. Roy P., Urakawa T., Van Dijk A. A., Erasmus B. J. 1990; Recombinant virus vaccine for bluetongue disease in sheep. Journal of Virology 64:1998–2003
    [Google Scholar]
  24. Van Dijk A. A. 1993; Development of recombinant vaccines against bluetongue. Biotechnology Advances 11:1–12
    [Google Scholar]
  25. Vlak J. M., Klinkenberg F. A., Zaal K. J. M., Usmany M., Klinge-Roode E. C., Geervliet J. B. F., Roosien J., van Lent J. W. M. 1988; Functional studies on the plO gene of Autographa californica nuclear polyhedrosis virus using a recombinant expressing a plO-beta-galactosidase fusion gene. Journal of General Virology 69:765–776
    [Google Scholar]
  26. Weyer U., Possee R. D. 1991; A baculovirus dual expression vector derived from the Autographa californica nuclear polyhedrosis virus polyhedrin and plO promoters: coexpression of two influenza virus genes in insect cells. Journal of General Virology 72:2967–2974
    [Google Scholar]
  27. Yamaguchi S., Fukusho A., Roy P. 1988; Complete sequence of neutralization protein VP2 of the recent US isolate bluetongue virus serotype 2: its relationship with VP2 species of other US serotypes. Virus Research 11:49–58
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-12-3629
Loading
/content/journal/jgv/10.1099/0022-1317-75-12-3629
Loading

Data & Media loading...

Most cited Most Cited RSS feed